Clinical Trials Directory

Trials / Completed

CompletedNCT05256043

Investigation of Critically Ill Patients With Newly Diagnosed Diabetes

Case-control Investigation of Critically Ill Patients With Newly Diagnosed Diabetes: Clinical Characteristics, Glucose Metrics and Outcomes

Status
Completed
Phase
Study type
Observational
Enrollment
1,777 (actual)
Sponsor
Stamford Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to investigate the clinical outcomes and glucose control metrics of critically ill patients with previously undiagnosed diabetes compared to those with known diabetes at the time of admission to the intensive care unit (ICU).

Detailed description

This case control study compares previously undiagnosed diabetic patients (defined as HbA1c \> 6.5% and no history of diabetes), to those with known diabetes, using 1:1 matching. Patients met inclusion criteria by having HbA1c available on ICU admission and at least four blood glucose tests during their ICU stay. Primary outcomes included ICU length of stay and inpatient mortality. Secondary outcomes included glucose metrics: mean blood glucose, coefficient of variation and percentage of patients who developed hypoglycemia.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTDiabetes DiagnosisHbA1c \> 6.5%

Timeline

Start date
2011-01-01
Primary completion
2019-12-31
Completion
2022-01-01
First posted
2022-02-25
Last updated
2022-02-25

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05256043. Inclusion in this directory is not an endorsement.